At a glance
- Originator Fujisawa
- Class Antifungals
- Mechanism of Action Glucan synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 17 Jun 2001 No-Development-Reported for Mycoses in Japan (Unknown route)
- 02 Nov 1998 New profile
- 02 Nov 1998 Preclinical development for Mycoses in Japan (Unknown route)